UnitedHealth Group Inc. (UnitedHealth (UNH)) is facing a legal headache that just won't quit. A group of shareholders has filed a derivative action against the company's current and former leadership, and the allegations are nothing short of explosive.

The lawsuit paints a picture of catastrophic governance failures stretching from September 2021 through July 2025. The plaintiffs argue that executive misconduct created artificial earnings growth, and when the truth came out, it erased more than $277 billion in stockholder value between December 2024 and August 2025. That's not a rounding error; that's a crisis.

Medicare Fraud and Algorithmic Denials

At the heart of the complaint are claims that UnitedHealth fraudulently inflated its Medicare Advantage revenue. How? By making members appear sicker than they actually were, using diagnoses that plaintiffs say were unnecessary. In 2021 alone, this allegedly captured $8.7 billion in federal funds. That's a lot of taxpayer money.

But it doesn't stop there. The lawsuit also alleges that the insurer systematically denied post-acute rehabilitation care using automated algorithms. Here's the kicker: when beneficiaries actually appealed, they won 99.7% of the time. Management apparently calculated that most patients wouldn't bother challenging the denials, so the risk was worth it. That's a cynical bet, and the plaintiffs are calling it out.

There's also an allegation that UnitedHealth routed above-market payments internally to sidestep federal profit caps. In other words, the company allegedly found creative ways to keep more money, even if it meant bending the rules.

Court Deception, Data Breaches, and Insider Sales

The complaint doesn't just focus on financial shenanigans. It also alleges that UnitedHealth misled a federal court about data firewalls during its $13 billion acquisition of Change Healthcare Inc. And those cybersecurity deficiencies? They allegedly contributed to the 2024 ransomware breach that exposed data belonging to about 190 million people. That's a massive breach, and the plaintiffs say it wasn't an accident.

Then there's the insider trading angle. The lawsuit names Stephen Hemsley, Andrew Witty, and former UnitedHealthcare CEO Brian Thompson, alleging they sold more than $237 million of UnitedHealth stock during the relevant period while material information about alleged misconduct remained under wraps. Selling stock while knowing the house of cards might collapse? That's a serious allegation.

The complaint also calls out former President and CFO John Rex. He served as CFO from 2016 until July 2025 and as president from April 2024 through July 2025, earning about $89.8 million in compensation from 2021 through 2025. During UnitedHealth's July 2025 earnings call, Rex disclosed that the revised outlook reflected $6.5 billion more in medical costs than anticipated and removed about $1 billion of previously planned portfolio actions. Two days later, the company announced his removal as president and CFO, effective Sept. 2, 2025. Talk about a quick exit.

Accounting Adjustments and Federal Fallout

The lawsuit also alleges that UnitedHealth used portfolio refinement transactions to boost profits by $3.3 billion, helping the company hit earnings targets before it sharply cut its financial outlook in 2025. That's a classic case of kicking the can down the road, and now the road has run out.

The fallout has been severe: leadership changes, a Massachusetts lawsuit alleging more than $100 million in Medicaid fraud, and credit-rating outlook cuts. Analysts cited in the complaint estimate that Medicare Advantage audits could result in as much as $20 billion in potential clawbacks. That's a lot of money that might have to be returned to the government.

UnitedHealth Group Price Action

As of Thursday's publication, UnitedHealth shares were down 0.89% at $401.96, according to market data. The market is clearly paying attention to these developments, and investors are feeling the jitters.

This lawsuit is a reminder that when corporate governance goes wrong, the consequences can be enormous. For UnitedHealth, the road ahead looks rocky, and the legal battles are just beginning.